Research Labs & Clinical Trials
Research in Dr. Appel’s laboratory focuses on developing new insights into neurodegenerative diseases, with a primary emphasis on amyotrophic lateral sclerosis (ALS). The major goal is to develop therapeutics that suppress neuroinflammation and the immune/inflammatory alterations that drive neurodegenerative disease progression.
Using the tools of human neuroimaging, including MRI, PET and EEG, the Neuroimaging Lab aims to clarify the neurobiology and improve the treatment of the following disorders causing cognitive impairment: Alzheimer, frontotemporal dementia, genetic underpinning of regional involvement patterns, neuroimaging correlates of social cognition, TBI, amyloid and tau imaging in acute and chronic concussion, timing and brain localization of tau deposition in patients with repeated head trauma, schizophrenia.
For more information: 281.222.9983
Amyotrophic Lateral Sclerosis & Neuromuscular diseases
For more information: 713.441.9120
For more information: 713.363.8390
For more information: 713.441.5801